Cases 61 - 70 of 404
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv02608
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv01489
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv22231
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Almirall, LLC v. Mylan Pharmaceuticals Inc.
as 1:2020cv00006
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Almirall, LLC
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
